driven by the PitchBook Platform
March 11, 2022
Biotech investment boomed with the onset of the pandemic, setting funding and valuation records across multiple stages. But market turmoil and waning investor appetites are like to push valuations back down.
March 9, 2022
Who do you ask for money when your companys mission is to bring back the woolly mammoth? Hollywood icons, blockchain elites, TikTok stars and venture capitalists, of course.
January 9, 2022
Elizabeth Holmes may have been found guilty of fraud, but the moral of the story is less clear.
October 7, 2021
Remote clinical trials were a necessity during the pandemic, but even now investor interest in companies offering these decentralized options doesn't appear to be waning.
September 30, 2021
Shares in the VC-backed biotech startup jumped by as much as 47% in its first day of trading on the London Stock Exchange, following an IPO that valued the company at $4.6 billion.
September 23, 2021
Biotech startup Oxford Nanopore could hit a valuation of up to $5.2 billion when it goes public via a rare London IPO in October.
September 12, 2021
In federal court, lawyers for the US government have begun pressing fraud charges against Elizabeth Holmes, founder of Theranos. Where are investors in the failed blood-testing startup today?
June 7, 2021
One investor is calling it "the most important technological revolution of our time."
March 30, 2021
This analyst note explores how investor interest in biotech startups drove the sector beyond its early-year projections and why VC-backed biotech & pharma financings are expected to remain strong.
October 23, 2020
This analyst note discusses VC investment in the biotech industry and examines the key differences between tech and biotech startup frameworks.
July 8, 2020
Biotech VC investing has evolved over the last few decades, as the biotechnology & pharmaceuticals industry has shifted from internal drug development to an M&A-based model.
April 8, 2020
On Wednesday, Keros Therapeutics became the latest biotech startup to pull off a public debut, roughly a month after raising fresh financing from venture capitalists.
March 23, 2020
A series of startups tried to offer at-home coronavirus sample collection kits, assuming they were in line with FDA guidance. Then on Saturday, the FDA explicitly banned them from doing so.
March 4, 2020
Anecdotally, the dissemination of venture capital beyond just a heavy concentration in Silicon Valley is a well-told story by now—and the data really drives the point home.
November 10, 2019
PE's buyout bonanza, the FCC's Civil War and Travis Kalanick's comeback join a chat with 10x Genomics CEO Serge Saxonov in our recap of the week.
© 2022 PitchBook Data. All rights reserved. PitchBook is a financial technology company that provides data on the capital markets.